Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Outcomes According to ECG Presentations in Infarct-Related Cardiogenic Shock in the Culprit Lesion Only PCI vs Multivessel PCI in Cardiogenic Shock Trial.
Zeitouni M, Akin I, Desch S, Barthélémy O, Brugier D, Collet JP, de Waha-Thiele S, Greenwood JP, Guedeney P, Hage G, Hauguel-Moreau M, Huber K, Kerneis M, Noc M, Oldroyd KG, Piek JJ, Rouanet S, Savonitto S, Serpytis P, Silvain J, Stepinska J, Vicaut E, Vrints CJM, Windecker S, Zeymer U, Thiele H, Montalescot G; CULPRIT-SHOCK Trial Investigators. Zeitouni M, et al. Chest. 2021 Apr;159(4):1415-1425. doi: 10.1016/j.chest.2020.10.089. Epub 2020 Nov 26. Chest. 2021. PMID: 33248059
One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S; CULPRIT-SHOCK Investigators. Thiele H, et al. N Engl J Med. 2018 Nov 1;379(18):1699-1710. doi: 10.1056/NEJMoa1808788. Epub 2018 Aug 25. N Engl J Med. 2018. PMID: 30145971 Free article. Clinical Trial.
Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock: A Substudy of the CULPRIT-SHOCK Trial.
Rubini Gimenez M, Zeymer U, Desch S, de Waha-Thiele S, Ouarrak T, Poess J, Meyer-Saraei R, Schneider S, Fuernau G, Stepinska J, Huber K, Windecker S, Montalescot G, Savonitto S, Jeger RV, Thiele H. Rubini Gimenez M, et al. Circ Cardiovasc Interv. 2020 Mar;13(3):e008537. doi: 10.1161/CIRCINTERVENTIONS.119.008537. Epub 2020 Mar 10. Circ Cardiovasc Interv. 2020. PMID: 32151161 Clinical Trial.
Frequency and Impact of Bleeding on Outcome in Patients With Cardiogenic Shock.
Freund A, Jobs A, Lurz P, Feistritzer HJ, de Waha-Thiele S, Meyer-Saraei R, Montalescot G, Huber K, Noc M, Windecker S, Zeymer U, Ouarrak T, Schneider S, Thiele H, Desch S. Freund A, et al. JACC Cardiovasc Interv. 2020 May 25;13(10):1182-1193. doi: 10.1016/j.jcin.2020.02.042. JACC Cardiovasc Interv. 2020. PMID: 32438988 Free article. Clinical Trial.
Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK Trial.
Guedeney P, Barthélémy O, Zeitouni M, Hauguel-Moreau M, Hage G, Kerneis M, Lattuca B, Overtchouk P, Rouanet S, Fuernau G, de Waha-Thiele S, Zeymer U, Sandri M, Akin I, Desch S, Thiele H, Montalescot G. Guedeney P, et al. JACC Cardiovasc Interv. 2020 May 25;13(10):1198-1206. doi: 10.1016/j.jcin.2020.04.003. JACC Cardiovasc Interv. 2020. PMID: 32438990 Free article. Clinical Trial.
Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial.
Guedeney P, Thiele H, Kerneis M, Barthélémy O, Baumann S, Sandri M, de Waha-Thiele S, Fuernau G, Rouanet S, Piek JJ, Landmesser U, Hauguel-Moreau M, Zeitouni M, Silvain J, Lattuca B, Windecker S, Collet JP, Desch S, Zeymer U, Montalescot G, Akin I; CULPRIT-SHOCK Investigators. Guedeney P, et al. Am Heart J. 2020 Jul;225:60-68. doi: 10.1016/j.ahj.2020.04.014. Epub 2020 Apr 30. Am Heart J. 2020. PMID: 32497906 Clinical Trial.
Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial.
Farhan S, Vogel B, Montalescot G, Barthelemy O, Zeymer U, Desch S, de Waha-Thiele S, Maier LS, Sandri M, Akin I, Fuernau G, Ouarrak T, Hauguel-Moreau M, Schneider S, Thiele H, Huber K. Farhan S, et al. JAMA Cardiol. 2020 Dec 1;5(12):1329-1337. doi: 10.1001/jamacardio.2020.3377. JAMA Cardiol. 2020. PMID: 32845312 Free PMC article. Clinical Trial.
Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial.
Robles-Zurita JA, Briggs A, Rana D, Quayyum Z, Oldroyd KG, Zeymer U, Desch S, de Waha-Thiele S, Thiele H. Robles-Zurita JA, et al. Eur J Health Econ. 2020 Nov;21(8):1197-1209. doi: 10.1007/s10198-020-01235-3. Epub 2020 Oct 7. Eur J Health Econ. 2020. PMID: 33029668 Free PMC article. Clinical Trial.
58 results